STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers.
van der Lelij, P., Newman, J.A., Lieb, S., Jude, J., Katis, V., Hoffmann, T., Hinterndorfer, M., Bader, G., Kraut, N., Pearson, M.A., Peters, J.M., Zuber, J., Gileadi, O., Petronczki, M.(2020) Life Sci Alliance 3
- PubMed: 32467316 
- DOI: 10.26508/lsa.202000725
- Primary Citation of Related Structures:  
6QB5, 6R7O, 6RRC, 6RRK - PubMed Abstract: 
The cohesin subunit STAG2 has emerged as a recurrently inactivated tumor suppressor in human cancers. Using candidate approaches, recent studies have revealed a synthetic lethal interaction between STAG2 and its paralog STAG1 To systematically probe genetic vulnerabilities in the absence of STAG2, we have performed genome-wide CRISPR screens in isogenic cell lines and identified STAG1 as the most prominent and selective dependency of STAG2-deficient cells ...